Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Progenic's GMK undergoes phase III clinical trials

Aug. 23, 1996

AltaRex awaits Canadian approval to begin Ovarex phase II/III trials

Aug. 23, 1996

European approval sought for new Rebif indications

Aug. 23, 1996

U.S. patent will issue covering GLIOMAB-H

Aug. 16, 1996

BEC2, ImClone Systems' therapeutic vaccine protected under U.S. patent

Aug. 9, 1996

Larifane shown effective in cervical dysplasia/cancer patients

July 26, 1996

Humanized CD38 antibodies for cancer/autoimmune disease treatment

July 26, 1996

Multikine enters Canadian phase I/II trial

July 12, 1996

Antitumor vaccines described by University of Pennsylvania

July 5, 1996

Human Genome Sciences reports discovery of TNF-gamma

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...